Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System AtrophyBOSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ...

On World Organ Donation Day KFSHRC Announces 10 Kidney Exchange Transplants Completed in 48 HoursRIYADH, Saudi Arabia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research ...

Corza Medical Launches Biomedical Textiles Innovation Lab to Accelerate OEM Product DevelopmentTAUNTON, U.K., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global manufacturer of surgical ...

GenesisCare Further Expands Its Adaptive Radiotherapy MR Linac Network GenesisCare, the UK’s leading independent cancer care provider, announces the expansion of their adaptive radiotherapy network ...

Bionova Scientific, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary of global conglomerate Asahi Kasei, has announced the opening of a 10,000 ...

Third Patient Treated with HG-CT-1 CAR-T Therapy and Completion of First Adult Dose Cohort LONDON, UNITED KINGDOM / ACCESS Newswire / August 15, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is ...

The looming changes to the UK Apprenticeship Levy are causing ripples across industries. For the healthcare sector, which often relies on Level 7 apprenticeships to address leadership skills gaps and ...

The Culture Media Market is undergoing a dynamic transformation, responding to the surging needs of biopharmaceutical ...

Tiziana Life Sciences has commenced patient dosing at Yale in its Phase 2a trial of intranasal Foralumab for non‑active SPMS, ...

Transitioning into biotech manufacturing from industries like pharma, engineering, or food production can be strategic with ...

Clinical trials are steadily becoming more complex, and the systems that support them must evolve in parallel to ensure ...

Science and technology rely on each other. Scientific progress fuels new technologies, while better technology helps science ...